A drug that helps children with the most common form of dwarfism grow taller has sparked an ethical debate within the dwarfism community.
Some parents hope that as well as increasing size, it will prevent serious health complications and improve their children’s independence. But critics worry that a treatment focused on increasing height sends the message that dwarfism is something that needs to be corrected.
